FIELD: medicinal virology. SUBSTANCE: vaccine strain A/92/17/89 is a recombinant prepared by crossing of epidemic virus A/Leningrad/92/89 (H1N1) with cold adopted temperature-sensitive strain A/Leningrad/134/57/17 (H2N2) - attenuation donor which is harmless for adult and children. Strain A/92/17/89 is actively reproduced in developing chicken embryos at optimal temperature (32 C), difference of infectious activity indices at 32 and 40 C - 6.75 lg ЭИД 50/0.2 ml. Recombinant inherited from actual epidemic virus 2 genes encoding surface proteins (hemagglutinin and neuraminidase) and 6 genes incoding internal proteins from attenuation donor. Genome of strain A/92/17/89 contains 3 ts-mutations that are typical for attenuation donor A/Leningrad/134/57/17 (H2N2). Strain A/92/17/89 is nonreactive for adult and children (age is 3-15 years) at intranasal administration and causes 4-fold increase of antibodies in blood in 61.9% of adult after a single vaccination. Strain is involved in ГКВ at number 2251. EFFECT: increased effectiveness of influenza strain.
Authors
Dates
1995-03-27—Published
1991-03-14—Filed